Poster Presentations-28th May, 10:00-14:00

1)      P063 THE EFFECT OF PENTOXIFYLLINE ON LIVER FUNCTION TESTS IN NON-ALCOHOLIC FATTY LIVER DISEASE NON-DIABETIC PATIENTS, By Raika Jamali

2)      P069 HELICOBACTER PYLORI SEROPREVELANCE IN IRAQI PATIENTS INFECTED WITH HEPATITIS C VIRUS, By Akram Ajeel Najeeb

3)      P070 SEROLOGICAL PROFILE OF HBV INFECTION AND THE ASSOCIATED RISK FACTORS AMONG HIV POSITIVE INDIVIDUALS IN SHIRAZ, SOUTHERN IRAN, By Nasrin Motazedian

4)      P072 HEPATITIS E VIRUS SEROPREVALENCE IN HIV POSITIVE INDIVIDUALS IN SHIRAZ, SOUTHERN IRAN, ByOmid Rudgari

5)      P074 PARTICULARITIES OF THE COURSE OF CHRONIC HEPATITISES OF MIXED VIRAL ETIOLOGY (HBV + HCV), BySaodat Azimova

6)      P077 SURVEY OF SEROLOGICAL AND VIROLOGICAL MARKERSOF HEPATITIS B IN PATIENTS CO-INFECTED WITH BOTH HIV AND HEPATITIS C, By Mohammad Mahdi Majzoobi

7)      P079 CHANGES OF EPIDEMIOLOGICAL MODEL OF HEPATITIS IN ILAM PROVINCE BETWEEN 2009-2012, By Khadijeh Javaheri

8)   P083 VIRAL LOAD CHANGES IN HEPATITIS C PATIENTS WITH DIFFERENT GENOTYPES, GOLESTAN PROVINCE, By Sima Besharat

9)  P088 PREVALENCE AND RISK FACTORS OF HEPATITIS C INFECTION IN BIRJAND, By Azadeh Ebrahimzadeh

10)  P091 PREVALENCE OF HCV GENOTYPES AMONG PRISONER PATIENTS WITH CHRONIC HEPATITS C INFECTION IN SOUTH KHORASAN PRISONS-2014, By Zohreh Azarkar

11)  P092 ASSOCIATION OF THE HEPATIC SORTILIN WITH REDUCED LEVEL OF HEPATIC HBSAG IN CHRONIC HEPATITIS B PATIENTS, By Ashraf Mohamadkhani

12)  P095 A SURVEY OF THE PREVALENCE OF DEPRESSION IN BLOOD DONORS WITH HEPATITIS C IN SHIRAZ, By Leila Kasraian

13)  P096 INFLUENCING FACTORS ON SUSTAIN VIROLOGICAL RESPONSE THROUGH PEG & RIBAVIRIN IN CHRONIC HEPATITIS C VIRUS, By Shahnaz Sali

14)  P097 OCCULT HEPATITIS B VIRUS INFECTION AMONG HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH ISOLATED HEPATITIS B CORE ANTIBODY IN ISFAHAN, IRAN, By Parisa Shoaei

15)  P100 NON-INVASIVE HISTOLOGIC MARKERS OF LIVER DISEASE IN PATIENTS WITH CHRONIC HEPATITIS B, By Shahnaz Sali

16)  P102 EFFECTS OF ORAL LEVAMISOLE AS AN ADJUVANT TO HEPATITIS B VACCINE IN HEALTH CARE WORKERS NON RESPONDER TO PREVIOUS VACCINATIONS: A RANDOMIZED CONTROLLED TRIAL, By Babak Sayad

17)  P104 THE THERAPEUTIC USE OF ANALGESICS IN PATIENTS WITH LIVER CIRRHOSIS: A LITERATURE REVIEW AND EVIDENCE-BASED RECOMMENDATIONS, By Mahsa Motavaf

18)  P105 HEPATOTOXICITY OF HALOGENATED INHALATIONAL ANESTHETICS, By Mahsa Motavaf

19)  P107 COMPARATIVE STUDY OF HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH HEPATITIS C AND HEALTHY PEOPLE AND PRESENT A STRUCTURAL MODEL, By Maryam Momeni

20)  P115 DETERMINATION OF GENOTYPE AND VIRALLOAD OF HCV AMONG THALASSEMIC PATIENT SUFFERING HEPATITIS, By Vahid Babaei

21)  P119 MOLECULAR GENOTYPING OF HEPATITIS C VIRUS IN THE GENERAL POPULATION IN IRAN, By Maryam Karkhane

22)  P120 HEPATITIS B VACCINATION COVERAGE AMONG DENTISTS IN IRAN: A SYSTEMATIC REVIEW AND META-ANALYSIS STUDY, By Milad Azami

23)  P123 PREVALENCE OF HEPATITIS B SURFACE ANTIGENPOSITIVE IN PREGNANT WOMEN REFERRED TOBEHESHTI HOSPITAL OF KASHAN –ISFAHAN, 2012, By Hasan Afzali

24)  P124 EPIDEMIOLOGICAL DISTRIBUTION, AND GENOTYPE CHARACTERIZATION OF HEPATITIS C VIRUS AMONG HIV PATIENTS IN KASHAN-IRAN, By Mansooreh Momen-Heravi

25)  P125 PREVALENCE OF HEPATITIS C IN INTRAVENOUS DRUG ABUSERS IN KASHAN, By Mansooreh Momen-Heravi

26)  P126 PREVALENCE OF INFECTIOUS DISEASE IN LIVER TRANSPLANT PATIENTS IN IMAM KHOMEINI HOSPITAL TEHRAN-IRAN, By Alireza Sharif

27)  P127 THE FREQUENCY OF INFECTION OF HBV, HCV AND HIV IN IDU, By Zarichehr Vakili

28)  P143 A REVIEW IN DENTAL MANAGEMENT IN VIRAL HEPATITIS, By Arghavan Tonkaboni

29)  P144 AN INTEGRATED MAP OF HBV GENOME-WIDE VARIATION FROM THE WORLD POPULATION PERSPECTIVE, By Mahmoudreza Pourkarim

30)  P147 A TETRA-PRIMER AMPLIFICATION REFRACTORY MUTATION SYSTEM–POLYMERASE CHAIN REACTION FOR GENOTYPING OF RS8099917 & RS12979860 IL28B POLYMORPHISMS IN IRANIAN HCV PATIENTS, By Tahereh Fakharian

31)  P150 NO ASSOCIATION OF GENETIC VARIATION AT PD1.5 LOCI WITH SPONTANEOUSLY CLEARANCE OF HCV INFECTION, By Jamal Sarvari

32)  P154 SEROPREVALENCE OF HEPATITIS B AMONG PREGNANT WOMEN IN IRAN, By Farhad Abbasi

33)  P155 EVALUATION OF THE FREQUENCY OF HEPATITIS B AND HEPATITIS C IN MAJOR THALASSEMIC PATIENTS IN BUSHEHR, IRAN, By Farhad Abbasi

34)  P158 LIVER HISTOPATHOLOGIC CHANGES IN HBEAG NEGATIVE, NORMAL ALT CHRONIC HEPATITIS B PATIENTS AND CORRELATION WITH VIRAL LOAD, By Elmira Ghoujeghi

35)  P167 MUTUAL EFFECTS OF HCMV INFECTION AND IMMUNE SYSTEM IN LIVER FAILURES, By Faezeh Maleki

36)  P170 PREVALENCE OF HEPATITIS B GENOTYPES IN PATIENTS WITH HEPATITIS B IN LORESTAN PROVINCE (2010-2014), By Mohamadreza Nazer

37)  P171 CHRONIC HCV INFECTION AND STROKE: A REVIEW, By Zia Obeidavi

38)  P172 NO ASSOCIATION OF IL-28B GENE POLYMORPHISM AT RS8099917 T/G WITH HCV INFECTION OUTCOME IN FARS PROVINCE, SOUTH OF IRAN: SPONTANEOUS CLEARANCE VERSUS CHRONIC INFECTION, Jamal Sarvari

39)  P174 A SURVEY OF TRANSFUSION REQUIREMENTS IN LIVER TRANSPLANTATION, By Leila Kasraian

40)  P177 RELATIONSHIP BETWEEN HEPATITIS B VIRUS DNA LOAD IN THE LIVER AND LIVER HISTOLOGY IN PATIENT WITH CHRONIC HEPATITIS B, By Tahmineh Biazar

41)  P179 ASSESSMENT OF HCV GENOGYPE IN IV DRUG ABUSER IN MASHHAD 2011-2013, BY REAL TIME PCR , WITH TAQ MAN METHOD, By Farshid Abedi

42)  P185 STIGMA OUTCOMES IN PATIENTS WITH HEPATITIS C, By Maryam Momeni